Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482365 · ClinicalTrials.gov registry record
National Registry and Blood Bank of Patients With Liver Cancer
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 151
- Enrollment target
NCT00482365 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 151 participants.
The verdict
NCT00482365 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 151 participants
- Enrollment target
Study Summary
RATIONALE: Gathering health information about patients with liver cancer over time may help doctors learn more about the disease and may help the study of cancer in the future. PURPOSE: This clinical trial is developing a national registry and blood bank of patients with liver cancer.
Interventions
- OTHER biologic sample preservation procedure
- OTHER medical chart review
- OTHER Patient interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2002-04 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482365
The ClinicalTrials.gov registry entry for NCT00482365 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which biologic sample preservation procedure is the first listed.
NCT00482365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00482365 about?
NCT00482365 is a clinical study titled "National Registry and Blood Bank of Patients With Liver Cancer". RATIONALE: Gathering health information about patients with liver cancer over time may help doctors learn more about the disease and may help the study of cancer in the future. PURPOSE: This clinical trial is developing a national registry and blood bank of patients with liver cancer.
What is the current status of trial NCT00482365?
This trial is currently completed. The enrollment target is 151 participants. The study started on 2002-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00482365?
The interventions under investigation include: biologic sample preservation procedure (OTHER), medical chart review (OTHER), Patient interview (OTHER).
Who is sponsoring clinical trial NCT00482365?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.